Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high […]
More Stories
Insider Buying: Inotiv, Inc. (NASDAQ:NOTV) Director Purchases 23,529 Shares of Stock
Inotiv, Inc. (NASDAQ:NOTV – Get Free Report) Director David Landman purchased 23,529 shares of the business’s stock in a transaction...
Donald Day Sells 2,321 Shares of SBA Communications Co. (NASDAQ:SBAC) Stock
SBA Communications Co. (NASDAQ:SBAC – Get Free Report) EVP Donald Day sold 2,321 shares of the stock in a transaction...
Proteome Sciences (LON:PRM) Trading 9% Higher – Should You Buy?
Proteome Sciences plc (LON:PRM – Get Free Report)’s share price was up 9% during trading on Monday . The company...
Comparing Everus (NYSE:ECG) & Landsea Homes (NASDAQ:LSEA)
Landsea Homes (NASDAQ:LSEA – Get Free Report) and Everus (NYSE:ECG – Get Free Report) are both finance companies, but which...
Sirona Biochem (CVE:SBM) Trading Down 18.8% – Here’s What Happened
Sirona Biochem Corp. (CVE:SBM – Get Free Report) shares fell 18.8% during trading on Monday . The company traded as...
Anebulo Pharmaceuticals Announces Private Placement Agreement with 22NW Fund & Institutional Investors
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) recently disclosed in an 8-K filing with the Securities and Exchange Commission that it entered...